Zobrazeno 1 - 6
of 6
pro vyhledávání: '"L R, Steranka"'
Autor:
R M, Burch, J R, Connor, J M, Bator, M, Weitzberg, K, Laemont, L, Noronha-Blob, J P, Sullivan, L R, Steranka
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 263(3)
NPC 15669, N-carboxy-L-leucine,N-[(2,7-dimethylfluoren-9-yl)methyl]ester, has been shown to inhibit several inflammatory reactions that depend upon recruitment of neutrophils into the primary lesion. In the present study we examined the effects of NP
Publikováno v:
Advances in experimental medicine and biology. 236
Autor:
L R, Steranka, E, Sanders-Bush
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 206(2)
The present experiments were designed to test the hypothesis that the long-term effects of p-chloroamphetamine (PCA) on serotonergic neurons in rats are mediated by a neurotoxic metabolite. The effects of well-known inducers and an inhibitor of hepat
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 244(2)
Bradykinin-stimulated prostaglandin synthesis was investigated in Swiss albino 3T3 fibroblasts (Swiss 3T3 cells) and bovine pulmonary artery endothelial cells (CPAE). Previous studies have indicated that bradykinin stimulates arachidonic acid release
Publikováno v:
Circulatory shock. 27(2)
The kallikrein-kinin system is activated during endotoxic shock, suggesting that bradykinin plays a role in the pathology of this disease. To test this hypothesis, a bradykinin antagonist, D-Arg-Hyp3-D-Phe7-bradykinin (NPC 567), was studied in consci
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 248(2)
The purpose of the present study was to examine the tissue selectivity of several [Arg1-D-Phe7]-substituted analogs of bradykinin. Unlike D-Arg-[Hyp3-D-Phe7]-bradykinin (NPC567), which antagonizes bradykinin-induced contractions both in rat isolated